Home
Search
Search Results
Previously Searched
3102 results found
Expand All
Apply All
3102 results found

BIO Applauds House Passage of Food and Drug Administration Reauthorization Act (FDARA)
Press Release  •  July 12, 2017
Urges swift Senate vote to ensure continuity of critical FDA functions Washington, DC (July 12, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the Food and Drug Administration Reauthorization Act (FDARA) by the U.S. House of Representatives:
Read More

BIO Statement on EPA’s Proposed 2018 Renewable Fuel Standards
Press Release  •  July 5, 2017
Washington, D.C. (July 5, 2017) – The Environmental Protection Agency’s proposed Renewable Fuel Standards for 2018 and biomass-based diesel volume for 2019 must be improved to support investment and capacity building for advanced and cellulosic biofuels, the Biotechnology Innovation Organization (BIO) said today. 
Read More

PDUFA At-A-Glance
Human Health, Legislation  •  Toolkit  •  July 5, 2017
PDUFA provides greater consistency, certainty and predictability in the FDA's human drug review programs while decreasing review times.
Read More

BIO Applauds Bipartisan Introduction of Renewable Chemicals Tax Credit
Press Release  •  June 30, 2017
BIO and its members thank Rep. Bill Pascrell (D-NJ) and Reps. Ryan Costello (R-PA), Brian Fitzpatrick (R-PA) and Linda Sánchez (D-CA) for introducing the Renewable Chemicals Act of 2017.
Read More

The BIO International Convention Closes after Four “Breakthrough” Days in San Diego
Press Release  •  June 23, 2017
The 2017 BIO International Convention  (BIO 2017), hosted by the Biotechnology Innovation Organizatio (BIO), closed today after four days of immersive, compelling programming united under the theme of “Breakthrough.”  BIO 2017 recognized past, present and future biotech breakthroughs that heal, feed and fuel the world
Read More

BIO Expands Cooperation with China-Based Pharma Group
Press Release  •  June 22, 2017
Memorandum of Understanding for Cooperation continues the longstanding relationship between BIO and RDPAC and deepens our cooperative efforts.
Read More

BIO Statement of Support for the Introduction of the STRONGER Patents Act of 2017
Press Release  •  June 22, 2017
Bill cracks down on false or deceptive patent demand letters, ensures urgently-needed fairness and finality in Patent Office post grant proceedings, eliminates diversion of PTO user fees, and helps American research-intensive companies protect their investments in innovation
Read More

New Report: Licensing of Academic Patents Has Contributed Up to $1.3 Trillion to US Economy
Press Release  •  June 21, 2017
Tech Transfer Has Supported Up to 4.2 Million Jobs Since 1996
Read More

BIO Releases Bioscience Economic Development Guide
Press Release  •  June 21, 2017
At the 2017 BIO International Convention, cabinet-level appointees representing Texas, Massachusetts, Rhode Island, and Puerto Rico participated in the report's release by discussing bioscience industry economic development and state policies that have proven successful in assisting industry growth.
Read More

BIO comments to FDA Regarding the Regulation of Intentionally Altered Genomic DNA in Animals
Letters, Testimony & Comments  •  June 20, 2017
BIO appreciates this opportunity to provide comments to the Food and Drug Administration (FDA) on its request for comments on the draft guidance for industry (GFI) #187, entitled Regulation of Intentionally Altered Genomic DNA in Animals2. This draft guidance would revise GFI #187 entitled “Regulation of Genetically Engineered Animals Containing Heritable Recombinant DNA Constructs” (current GFI #187)3. 
Read More